Rocuronium Bromide Injection · 1,304 days since initial FDA posting
Brand: ROCURONIUM
FDA lists Rocuronium Bromide Injection as Active Shortage (Piramal Critical Care Inc.).
Availability on file: Limited Availability
Rocuronium Bromide Injection: Active Shortage
Limited Availability Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Rocuronium Bromide Injection
- Manufacturer
- Piramal Critical Care Inc.
- Dosage Form
- Injection
- Presentation
- Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 66794-228-41)
- Package NDC
- 66794-228-41
Status & Timeline
- Status
- Active Shortage
- Availability
- Limited Availability
- First Reported
- Feb 15, 2023
- Last Updated
- Dec 18, 2025
- Therapeutic Category
- Anesthesia
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
On allocation
Nearby, Other Rocuronium Shortage Records
Rocuronium Bromide Injection
Piramal Critical Care Inc.
Injection
Rocuronium Bromide Injection
Meitheal Pharmaceuticals, Inc.
Injection
Rocuronium Bromide Injection
Meitheal Pharmaceuticals, Inc.
Injection
Rocuronium Bromide Injection
Sandoz Inc.
Injection
Rocuronium Bromide Injection
Sandoz Inc.
Injection
Rocuronium Bromide Injection
Eugia US LLC
Injection
FDA reason on file: On allocation. General shortage guidance lives on the tracker hub.